CompletedPhase 2NCT01543581

Vismodegib for Treatment of Basal Cell Carcinoma

Studying Intraoral basal cell carcinoma

Last synced from ClinicalTrials.gov May 11, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Abel Torres, MD
Principal Investigator: Abel Torres, MD
Professor and Chairman, Department of Dermatology
Intervention: Vismodegib(drug)
Enrollment: 3 enrolled
Eligibility: 18 years · All sexes
Timeline: 2012 – 2013

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01543581 on ClinicalTrials.gov

← Back to all trials